Analytical Data
-
Gene name
C10orf93
- Application
-
Alternative Names
CFAP46; C10orf123; C10orf124; C10orf92; C10orf93; TTC40Cilia- and flagella-associated Protein 46; Tetratricopeptide repeat Protein 40
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8IYW2
-
Expression Region
1-247aa
-
AA Sequence
MDLVITQELARAESQQDAASLKKAYELIKSANLGKSEFDPSESFSPDLFVLCAEQALKMRQPEVSEDCIQMYFKVKAPITQFLGRAHLCRAQMCAPKSAENLEEFENCVTEYMKAINFAKGEPRYYFLVYNASVLYWQMVRPFLKPGYRHHLIPSLSQIINVLSQTEEEDKEWRAELMLELLECYLQAGRKEEAARFCSTAAPFIKSHVPQKYRQIFSVMVNQRIRNRDVRSNFLKSHCSENCVEIT
-
Molecular Weight
55 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C10orf93, also known as chromosome 10 open reading frame 93, is a gene of significant interest in various biomedical research fields due to its potential role in cellular processes and disease mechanisms. Initially identified through genomic studies, C10orf93 is believed to be involved in crucial biological functions, including cell signaling pathways and immune responses. Recent studies have linked alterations in the expression of C10orf93 to several health conditions, including autoimmune diseases and some cancers. Given the increasing relevance of protein-based therapies, researchers are focusing on the recombinant expression of C10orf93 to elucidate its structure-function relationships and explore its potential as a therapeutic target. The generation of recombinant C10orf93 protein allows for in-depth functional analyses, enabling the investigation of its interactions with other proteins and cellular components. Furthermore, understanding the post-translational modifications and molecular mechanisms underlying C10orf93 function could provide insights into disease pathology and identify novel biomarkers for early diagnosis. Overall, the study of C10orf93 recombinant proteins holds promise for advancing our knowledge of disease mechanisms and developing innovative therapeutic strategies.
